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Abstract
Background and objective The spread of self-care holds the promise
of containing chronic illness burden. Falling within the framework
of a FP7 collaborative research project, this paper reports the views
of key informants from six countries regarding who the main stake-
holders are at diﬀerent levels in the support system for self-care for
patients with chronic illness (SSSC) and how they accomplish their
role and collaborate.
Methods 90 Interviews with purposefully selected key informants
from Bulgaria, Greece, the Netherlands, Norway, Spain and Uni-
ted Kingdom were conducted. Interviews involved government
and local authorities, politicians, academics, health professionals
and private sector representatives. Interviewers followed an
expert opinion-based guide. Analysis involved a cross-country
examination with thematic analysis and framework method
techniques.
Results Key informants described the ideal SSSC as inclusive, inter-
dependent and patient-centred. The following main stakeholders in
SSSC were identiﬁed: patients, governments, health-care profession-
als, associations, private companies and the media. In the current
SSSCs, collaboration among stakeholders within and across diﬀer-
ent levels was said to be lacking. Patients were seen as playing a
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passive subordinate role based on the following: their own attitudes;
the paternalistic and medicalized attitudes of the health-care profes-
sionals; their misrepresentation by patient associations; and their
exposure to the damaging inﬂuences of media and industries.
Conclusions Making SSSC patient-centred constitutes the greatest
challenge for European authorities. Strategies must be revised for
promoting patient participation. They should undergo changes so as
to promote industry and media social responsibility and patient
association advocacy capacity.
Background
Fast-moving social and demographic changes in
recent years have imposed great challenges on
health systems. A critical example of this is the
enormous and rising prevalence of chronic illness
which, according to the World Health Organisa-
tion (WHO), could account for 57 percentage of
the global burden of disease by 2020.1 Because
such a burden would be overwhelming and pos-
ing a threat to the sustainability of health
systems, new strategies for tackling chronic ill-
ness are emerging. Among the latter is self-care,
which can be understood as ‘the care taken by
individuals towards their own health and wellbeing
[that] comprises the actions they take to lead a
healthy lifestyle; to meet their social, emotional
and psychological needs; to care for their long-
term condition; and to prevent further illness
or accidents’.2
Evidence suggests that the main intermediate
objective of self-care, sustainable behaviour
change, can be better attained through multilevel
approaches (individual, community, organiza-
tional and systemic levels) that address processes
involved in illness management at diﬀerent sys-
temic levels.3,4 This is not surprising because
ﬁndings from qualitative research have revealed
that to engage in self-care tasks, patients feel the
need for diﬀerent types of support, stemming
from a variety of sources (e.g. Instrumental, psy-
chosocial and relational support from health-
care professionals, relatives and peers).5 The
corollary is that the development and deploy-
ment of self-care strategies require the
involvement and coordination of multiple stake-
holders at diﬀerent systemic levels.
Moreover, this has implications for the design
of support systems for self-care for patients with
chronic illness (SSSCs), an endeavour that poli-
cymakers and governments across Europe have
gradually incorporated into the broader agenda
of public health, health promotion and
patient-centred care.6,7 In particular, the main
implication is that SSSC should adopt a social–
ecological approach that supports patients and
their capacity for self-care by addressing not only
individual factors but also environmental
inﬂuences spanning macro-, meso- and micro-
contextual levels. Indeed, environmental inﬂu-
ences such as governance arrangements within
welfare and health-care systems (macro-level),
services provided by voluntary and community
organizations (meso-level) and patient domestic
and employment context characteristics (micro-
level) have been identiﬁed as inﬂuencing self-
care support.6,8
The operationalization of this social–ecological
SSSC is challenging. While research abounds in
terms of how support for self-care is inﬂuenced
by individual factors, understanding the impact
of environmental inﬂuences remains scarce.9
This makes it diﬃcult to establish which environ-
mental aspects should be prioritized in the design
of SSSC and who could and should be involved
and held responsible for their management.
In summary, it is necessary to broaden our
understanding regarding how support for self-
care is inﬂuenced by environmental factors in
order to facilitate the design of SSSC, thus
allowing for the implementation of informed
initiatives relevant in the everyday life of individ-
uals. To accomplish this general aim across
selective settings in Europe, a project funded
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under the EU’s 7th Framework Programme,
entitled EU-WISE (Self-Care Support for People
with Long Term Conditions, Diabetes and
Heart Disease: A Whole System Approach)10
included an exploration of the inﬂuence of the
broader socio-economic and policy environment
on the capacity of self-management. More
speciﬁcally, this investigation included the iden-
tiﬁcation and examination of views expressed by
key informants in relation to (1) emerging poli-
cies and practices regarding type 2 diabetes and
self-care; (2) impact of macro- and meso-level
inﬂuences on the SSSC for type 2 diabetes; and
(3) roles, division of labour and relationships of
stakeholders on the micro-, meso- and macro-
level of the SSSC for patients with chronic illness
and type 2 diabetes.
Most relevant ﬁndings related to the views
expressed by key informants on policy practices
and meso-level inﬂuences on type 2 diabetes and
self-care have been reported elsewhere.9,11 This
paper focuses on reporting the ﬁndings related to
the views of key informants from six European
countries regarding who the main stakeholders
are at diﬀerent levels in the SSSC and how they
should ideally participate and interact among
one another. Key informants’ perspectives on the
actual levels of coordination and collaboration
between these stakeholders are also examined.
Methods
The EU-WISE exploration of the roles, division
of labour and relationships of stakeholders in
the SSSC for patients with chronic illness and
type 2 diabetes involved interviews with key
informants from a range of socio-economic,
institutional and health-care contexts that could
inﬂuence the organization of and experiences
with SSSC. These contexts were the EU-WISE
project partner countries: Bulgaria (BG), Greece
(GR), the Netherlands (NL), Norway (NO),
Spain (ES) and United Kingdom (UK). Each
partner country obtained ethical approval for
the project from their pertinent Ethics Commit-
tee. A pan-European approach to study the
issue was preferred as it can provide more robust
insight into context-dependent phenomena than
single studies and it accelerates the generation,
accumulation and transfer of knowledge across
countries. Furthermore, it oﬀers the opportunity
to identify a basic set of networking structures
and practices that suggest suitability for diﬀer-
ent contexts, and thus, can enrich the
development of supranational strategies and
policies directed at strengthening SSSCs.
The selection of key informants was purpose-
ful and aimed at maximizing variation and expert
sampling. A special eﬀort was made to include a
wide variety of participants from diﬀerent ﬁelds
who had ﬁrst-hand inside knowledge regarding
policy, structures and practices related to self-
care support for chronic illness and type 2 dia-
betes. These participants included government
representatives and local authorities, as well as
politicians, academics, health professionals (i.e.
general practitioners, specialist physicians, nurses,
pharmacists and dieticians) and representatives of
the private sector (i.e. drug, technology, food and
insurance companies). Patients were not included
because although they could oﬀer a diﬀerent per-
spective on the issues under study, their opinions
would not be based on expertise in terms of inform-
ing, shaping and spreading the uptake of practices
and policies related to health programmes.
Potential key informants were identiﬁed
through personal knowledge of project team
members, snowballing techniques and examina-
tion of policy statements and organizational
websites in each partner country. Once identiﬁed,
potential key informants were approached via
telephone calls or emails and given a brief expla-
nation of the project and interview topics.
Further information and a consent form were
emailed through a second contact, after which
approval to participate was obtained and inter-
views were scheduled.
Table 1 presents details on the backgrounds
of the 90 key informants interviewed (15 per
partner country).
Interviews were conducted face to face or
via telephone by project team members or
thoroughly trained interviewers who followed
an interview guide based on expert group dis-
cussions. As summarized in Table 2, the
latter was adapted to each partner country
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and included questions reﬂecting the main
interview topics. Interviews lasted between 30
and 90 min.
Interviews were audio-recorded and tran-
scribed verbatim into Bulgarian, Greek, Dutch,
Norwegian, Spanish and English. Some of the
Dutch interviews were not audio-recorded. The
latter were analysed on the basis of detailed sum-
maries typed immediately after each interview.
Anonymity of key informants’ contributions
was maintained in the presentation of the data.
The analysis of the transcripts involved a
three-stage cross-country examination guided by
thematic analyses and techniques from the fra-
mework method.12,13. Each partner country
provided a preliminary analysis of a set of inter-
views that were examined together so that
consistent themes and topics could be identiﬁed
across countries, leading to the emergence of a
common thematic framework. Following the
reading of the transcripts and ﬁeld notes, each
partner country undertook a thematic and tex-
tual intracountry analysis that led to the
identiﬁcation of recurring themes and sub-
themes. Selected quotes illustrative of these
themes were translated into English to allow for
discussion among partner countries in two com-
parative cross-cultural data analysis clinics and
for supplementary discussions with individual
partners. The initial coding of each country’s
data set was subjected to an adapted compara-
tive method to identify convergent and divergent
themes across topics. Project team members
from each country accounted for cross-cultural
diﬀerences in the data sets while working
towards shared meanings to reach a consensus
on the meanings of key topics.
Findings
Two main themes emerged in relation to the
roles, division of labour and relationships of
stakeholders in the SSSC for patients with
chronic illness and type 2 diabetes. The ﬁrst
theme, ‘Identity of stakeholders in the SSSC’,
Table 1 Key informants’ background*
Health professional
Policymaker/
politician Academic
Industry representatives
(Drug/Tech)/health
facilities managers
General
practitioner/
specialist Nurse
Other
(pharmacist,
dietician)
Bulgaria 11 1 3 5 5 5
Greece 6 2 7 3 3 3
The Netherlands 2 2 11 6 3 1
Norway 5 4 6 7 2 2
Spain 5 3 7 6 7 3
UK 6 1 8 3 9 3
*15 key informants per country who, in many cases, could be described under different categories.
Table 2 Interview guide (questions adapted to each partner
country)
• What are the key changes, policies, innovations in self-care
support and diabetes type 2 over the last 10 years? Why
have these been the most important ones? What changes
have these led to?
• Why do you think policy has changed in the way that it
has?
• Who are the most important stakeholders in this area?
How have they influenced the agenda around self-care
support?
• What is the role of drug companies nationally/
internationally? Do you have a view of current policy
around the role of drug companies or how they influence
the agenda in this area?
• What is the role of telecare companies?
• What is the involvement of other private companies in
self-care support?
• How is the broader health-care system organized?
• What are the public attitudes to self-care support and
diabetes type 2?
• What are the media constructions of the epidemic of
diabetes type 2 and who is at risk?
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reﬂects the views expressed by key informants
regarding who the main stakeholders are at dif-
ferent levels in the SSSC and how they should
ideally operate and interact. The second theme,
‘Attitudes and collaboration of stakeholders in
the SSSC’, reﬂects the perceptions of key infor-
mants concerning how these stakeholders
actually recognize the roles assigned to them and
how they are currently acting, coordinating and
collaborating to support self-care. Therefore, the
second theme abandons the descriptions of the
key informants’ expectations on how the SSSC
should operate to focus on their perceptions of
the actual state of aﬀairs.
Identity of stakeholders in the SSSC
According to the key informants, if new chronic
illness and type 2 diabetes strategies (and subse-
quently self-care) are to be promoted, multiple
stakeholders should intervene in a complemen-
tary and coordinated manner. Among these
stakeholders, key informants cited patients, gov-
ernments, health-care professionals, profes-
sional, scientiﬁc and patient associations, private
companies (such as drug, technology and food
companies) and the media. As presented in
Fig. 1, these diﬀerent stakeholders belong to
and operate at diﬀerent SSSC levels, including
the micro-, meso- and macro-levels.
Key informants described diﬀerent functions
for each of these stakeholders that, far from
being hermetic, are complementary and interde-
pendent and thus prescriptive of a particular
pattern of interactions within the SSSC. The
optimal relationships among stakeholders in the
SSSC for patients with chronic illness and type 2
diabetes as described by key informants are pre-
sented in the left diagram of Fig. 2.
As illustrated in the left diagram of Fig. 2, key
informants from the six countries were consis-
tent in stating that the SSSC should be patient-
centred. In this arrangement, all eﬀorts and
resources for self-care are organized around
patients who, given their central position,
become empowered to establish active and direct
relationships with health professionals and
patient associations. These relationships are
expected to give patients a means by which to
make an impact not only on their own care but
Figure 1 Stakeholders at different levels
in the SSSC.
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also on general standards of care, health services
designs and health policies. Ultimately, key
informants expressed that patients’ empower-
ment and participation, aside from being
desirable to themselves, are necessary for meet-
ing the demand for increasing the responsibility
of patients in their own health management and
decision making. While key informants from the
UK and ES linked this demand with the need to
contain burdens on the health-care sector, Nor-
wegian key informants linked it with a process
of increased democracy.
From the key informants’ perspectives, in the
ideal SSSC, health-care professionals should
serve as some of the closest partners of the
patients at the micro-level (see left diagram of
Fig. 2). Health-care professionals are expected
to focus on helping patients increase their auton-
omy to the maximum extent possible, thus
allowing an eﬀective implementation of self-care.
Patient associations were described as the
most important instruments for patients for
inﬂuencing the health policies and practices of
health professionals. They should maintain a
close relationship with patients, advocating for
patient aspirations and needs in terms of care
and self-care, and at the same time, they need to
maintain ties and collaborate with health-care
professionals, professional associations and
health-care planners.
According to key informants, the input of
patient associations and professional associa-
tions should help authorities at diﬀerent levels to
fulﬁl their roles in developing and maintaining
the SSSC. These roles include the development
and enforcement of self-care, chronic illness and
type 2 diabetes policies; the organization of
health systems; the allocation and distribution
of resources; and regulating and overseeing the
environment wherein the SSSC is framed. This
includes the regulation of industry (especially
the pharmaceutical and food industries) and the
media to protect the public from unhealthy envi-
ronmental inﬂuences.
Key informants charged industry and the
media with the duty of collaborating with health
professionals and organizations so as to share
accurate information about chronic illness and
self-care with the public, break myths associated
with chronic illness and self-care, and increase
health literacy. More importantly, key infor-
mants highlighted the need for industry and the
Figure 2 Optimal and current relationships among stakeholders in the SSSC as described by key informants.
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media to self-regulate, fulﬁlling their social
responsibility of avoiding environmental impacts
that endanger public health.
In addition to being consistent about how the
SSSC should be characterized as patient-centred
and inclusive, key informants also agreed that
this idealized model is far from the current reality
that is depicted by the right diagram in Fig. 2.
Attitudes and collaboration of stakeholders in
the SSSC
Within the theme regarding the current roles
of the stakeholders, coordination and collabo-
ration, three subthemes emerged highlighting
the perceived deviations from the ideal model
of SSSC, as observed by the key informants:
(1) distortions in micro-level stakeholder atti-
tudes and relationships, (2) distortions in
meso-level stakeholder attitudes and relation-
ships with stakeholders at the micro-level and
(3) distortions in macro-level stakeholder atti-
tudes and relationships with stakeholders at
the micro-level.
Distortions in micro-level stakeholder attitudes
and relationships
As presented in the right diagram of Fig. 2, key
informants were in agreement that the central
role of patients in the SSSC that had been urged
had not been developed or put into practice.
Instead, patients were seen as playing a passive
and subordinate role due to inﬂuence from the
media and the private sector and considered to
be under the dominance of paternalistic health-
care professionals.
According to the key informants, the subordi-
nate relationship with health-care professionals
was accepted and even promoted by large sectors
of patients. For example, key informants from
GR and ES stated that elderly people are used to
having a paternalistic relationship with health-
care professionals and thus may not have the
cultural inclination, experience, skills or health
literacy to participate in decision-making pro-
cesses that aﬀect their health and self-care. Key
informants from the UK noted that younger
patients were also having problems taking on a
proactive role in self-care due to a lack of basic
skills required to undertake simple self-care tasks
such as cooking. This may result in an increase
in patient preferences for medicalized care that
relies on expert instructions and control.
For type I diabetes things are diﬀerent because the
patients are young. In type II (. . .) it’s extremely
diﬃcult to persuade someone that their health
does not solely rely on the doctor’s decision on the
units of insulin they take in the doctor’s oﬃce, but
that they too have to do something. To a large
extent it shifts the doctor-patient relationship from
how it had been previously established (GR1; Epi-
demiologist and internist)
People prefer more a paternalistic doctor that tells
them what they have to take and what they have
to eat (. . .) this demands from them less suﬀering
and anxiety than having to learn to manage things
for themselves, and it requires less eﬀort on their
part (. . .) I think this is a problem created by the
doctor-patient culture in this country, where peo-
ple are used to that ‘Mr Doctor says I have to take
these pills and I take them, and I don’t want to
know’ (. . .) it also depends on the type of popula-
tion: now there are younger people who tend more
to seek information themselves, but the average
diabetic patient who ﬁnds themselves in this area
of Endocrinology is over 70, and has had diabetes
for 30 years now, and has always done whatever
he was told to do, so it’s hard for them to make
their own decisions (ES6; Endocrinologist and
academic)
There’s also a lot of concerns about how as a
nation, I’m not just talking Scotland here, I’m
talking UK, is for how many people no longer
even have very basic cooking skills and actually
think that being able to cook means that you can
do things like put something in a microwave
(UK7; Academic)
Nevertheless, key informants explained that
the subordinate position of patients is also
perpetuated by health-care professionals. Key
informants stated that while health-care profes-
sionals’ attitudes towards promoting patient
autonomy and self-management are noticeably
improving, their practice is still dominated by
paternalism. This was mainly attributed to the
overexposure of health-care professionals to
medicalized paradigms and to existing practical
barriers for implementing patient-centred
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approaches, such as insuﬃcient time, training,
incentives, autonomy and multiprofessional
human resources.
The way doctors behave is paternalistic and conde-
scending and preserves their status quo (. . .) It is
necessary to change the consciousness of patients,
the training of doctors, to alter the behavioral
model of medical personnel and it is important to
start with the education at the medical universities
(BG10; Academic)
Doctors are so much under time pressure to see
so many patients that writing a prescription is a
lot easier than taking that extra 5 min to ﬁnd
them the proper service (UK13; Drug company
representative)
The satisfaction felt by the patients due to the ren-
dering of services which they would not otherwise
have, is the only incentive that I see (. . .) In Eng-
land recently, 8 years ago, ﬁnancial and personal
incentives regarding quality of life were given (. . .)
and after 5 years there was some improvement in
health indicators (GR7; General practitioner)
You don’t have an agent for the implementation
of those recommendations, you have an agent for
the implementation of all the drug recommenda-
tions – they’re called doctors (. . .) Where are all
these behaviour change experts? (UK9; Social pol-
icy campaigner and academic)
More encouragingly, key informants from the
UK and ES observed that nurses seem more
inclined to participate in the development of less
patronizing and more egalitarian relationships
with patients and thus to support and pioneer
the implementation of new self-care strategies.
Nurses’ professional ethos and the opportunity
that the spread of self-care presents for the
expansion of their professional role were high-
lighted as the reasons for nurses to take such a
favourable stance.
Distortions in meso-level stakeholder attitudes
and relationships with stakeholders at the
micro-level
Key informants stated that patients are disem-
powered and relegated to a minor passive role
in the SSSC, not only by their own attitude and
their health-care professionals’ paternalistic and
medicalized attitudes but also because they are
misrepresented in patient associations. As pre-
sented in the right diagram of Fig. 2, in most
countries (especially BG and ES), the patient
association sector is small, fragmented and
immature. Their own needs for development
and survival lead them to focus on delivering
services to patients rather than on advocating
for them.
Look how many patients’ organizations there are
and each one lobbies for its own interests, but they
are not interested in educating the patients and
defending their rights (BG10; Academic)
They always saw themselves as advisory and then
(. . .) the only way to grow was to deliver services
(. . .) you’ve now got a not for proﬁt organisation
that has spun oﬀ to deliver self-management and
indeed commercial organisations who now say we
can do it better than you (UK9; Social policy cam-
paigner and academic)
In addition, their ﬁnancial needs lead patient
associations to strive for partnerships with
stakeholders, such as professional and consumer
associations and private companies. This has
given rise to a shift in the agendas of patient
associations from patient-centred to one driven
by the interests of industry and professionals.
It isn’t the patients the ones who represent them-
selves, but the consumers. Traditionally, the
perspectives of consumers and patients are radi-
cally diﬀerent, consumers are generally supporting
the government stance at all times, and the
patients, obviously, are more aggressive in
demanding what they consider they need (. . .)
Nowadays, the patients don’t have a great inﬂu-
ence on diabetes or on any other illness (ES4;
Drug company representative)
They’re very (. . .) one sided because it seems like
they work very closely with medical professionals
so everything they worked on was related to health
care professionals so there wasn’t much going on
in terms of (. . .) health psychology or other areas
where there is research being done (UK8; Aca-
demic and policy advisor)
In the UK, where the patient association
sector appears to be more advanced, key infor-
mants noted that truly patient-driven associ-
ations tend to be single-issue campaigns without
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the ability and interest in promoting and seeing
the bigger picture, and as a result, they are disre-
garded and marginalized.
There is this other charity (. . .) which was set up to
campaign against human insulin which they
believed caused cancer and is a true patient organi-
sation (. . .) they’re not quite as mad. It’s a very,
very small group and they’re marginalised as being
nutty. I think they probably are the foundation for
a proper patient group but they’re minor, minor,
tiny, tiny, considered nutty (UK4; Academic and
policy advisor)
The corollary of the failure of patient associa-
tions to fulﬁl their role of representing patients’
interests and views to the authorities is that the
inﬂuence patients have over health-related poli-
cies was considered to be rather marginal.
Distortions in macro-level stakeholder attitudes
and relationships with stakeholders at the
micro-level
Remarkably, stakeholders that should be placed
in the most distant position from stakeholders at
the micro-level were identiﬁed by key informants
as the ones that ﬁnd ways to establish direct con-
tact with them (See right diagram of Fig. 2). For
example, pharmaceutical companies were said to
strive for establishing direct contact with both
professionals and patients by means of ﬁnancing
the training and research of professionals or by
getting involved in patient associations and edu-
cational activities. In most of the participant
countries (UK, BG, ES, GR), this was said to
occur despite existing regulations restricting
these relationships.
There is a company which teaches patients how to
take their insulin at home. Now, no company
has been contracted with oﬃcial bodies which
provide such assistance (GR1; Epidemiologist and
internist)
Most of the pharmaceutical companies take part
together with the medical experts in training
modules for patients, the most active participants
being the companies producers of insulin (BG15;
Internist)
Key informants representing pharmaceutical
companies alleged that their activities with
professionals and patients are only intended to
contribute to the SSSC while adding value and
diﬀerentiating their products in the marketplace.
However, the rest of the key informants reiterated
that pharmaceutical companies have ulterior
motives for their formation of close relationships
with professionals and patients. For example, by
organizing training and educational activities,
pharmaceutical companies have the opportunity
to introduce informational biases that help
reinforce the culture of medicalization most
favourable to their organizational interests: maxi-
mizingmedication consumption and sales.
There is now more of a tendency in some spheres
to actually put people on type 2 diabetes with insu-
lin a bit earlier on (. . .) obviously general
practitioners base their clinical decisions on guide-
lines but to some extent the guidelines are
informed by the evidence (. . .) and unfortunately
the evidence base that is currently available is
predominantly driven by the pharmaceutical com-
panies (. . .) there are lot more agendas at play than
we might want to think (UK7; Academic)
I just see their role very much as funding the kind
of research that ensures that their products get on
to patient prescriptions in order to maximize proﬁt
(UK7; Academic)
One Spanish interviewee explained that phar-
maceutical companies, unlike IT or insurance
companies, have not understood the importance
and irreversible character of recent changes to
health systems, and thus, they have committed a
strategic error by failing to identify a new mar-
ket niche.
In the last forty years the pharmaceutical industry
has not cured hardly anything. What it has done is
to turn loads of patients into chronic patients. The
drugs that are now out there pull in the same direc-
tion (. . .) An interesting thing that may happen to
them is that they are launching products that they
are not going to be able to sell because the market
is changing. They don’t understand that their cus-
tomer organisation is going to be very diﬀerent
from the organisation they used to sell to. A com-
pany should divert its attention to the payer who is
in control (ES10; Academic and policymaker)
IT, telecare and telehealth companies were
better regarded by key informants; they
explained that their interests are more aligned
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with the philosophical underpinnings of chronic
illness and self-care strategies. Thus, despite their
incipient development and marginal impact on
the SSSC, telecare and telehealth companies were
welcomed into the system with less suspicion.
Nevertheless, some key informants highlighted
that the potential for telecare and telehealth
strategies to enhance the system of support for
self-care would be missed if their focus on the
design and development of their products shifted
from a patient-focused approach to a health-care
professional-focused approach. Indeed, telecare
and telehealth products that are commercialized
only as tools for the convenience of professionals
and to save them time could perpetuate paternal-
ism in the relationships between professionals
and patients.
The mobile phone intervention has a lot of poten-
tial but you’ve got to be very careful how you
organise it because the classic model is send your
information to the healthcare professional and
they’ll tell you whether you have a problem. That’s
totally disempowering and that’s a very common
telehealth model currently practiced (. . .) which
was designed to be for the convenience of the
physicians (UK9; Social policy campaigner and
academic)
Finally, food companies and the media were
noted as the least compromised in the advance-
ment of SSSC. According to key informants,
food companies’ sales strategies and false adver-
tising practices (i.e. presenting their products as
almost medicinal) and media sensationalism are
harmful to people’s eating behaviours and to the
public’s image of chronic illness and type
2 diabetes.
You go to X supermarket and there is the trick:
there is something like a ‘healthy best-oﬀer’ but
there is still the oﬀer of unhealthy food that creates
diabetics and obese people (ES10; Academic and
policymaker)
The labelling here (. . .) is ludicrous. Low fat. What
does low fat mean? One or 2 kilocalories below the
full fat version but still 5 times higher than having
a piece of fruit (UK9; Social policy campaigner
and academic)
Some news coverage are little ‘bombs’ that go oﬀ,
to do this that or the other (. . .) all undermine our
work a lot, because misinforming is very danger-
ous. As for the Internet, they come to my oﬃce
having already decided what their therapy should
be. It’s tiring and it leads to mistakes and it under-
mines the doctor-patient relationship (GR9;
General practitioner and internist)
Type 2 diabetes has had a focus in the media and it
has been a biased focus upon overweight and per-
spectives – well one eats too much and doesn’t
move; that’s why you have got diabetes type 2. It
is obviously a stigmatising situation for those with
diabetes type 2 (NO8; Nurse, professional associa-
tion leader and policymaker)
The responsibility for the negative relation-
ships between the industries, the media and the
public was laid on the industries and media but
also on the authorities. While private companies
were accused of lacking social responsibility
and refusing to self-regulate, authorities were
charged with failing to adequately regulate and
oversee the environment of the SSSC.
Other industries have somewhat started to self-
regulate, but it is the agri-food industry which
needs to do something serious about sugar and salt
(ES10; Academic and policymaker)
The media do not reﬂect on their educational role
(. . .) Most of them told us: ‘This is not our work.
Our work is not educating or training people. This
is your work. Our work is just to inform about
whatever happens thanks to our freedom of press’
(ES10; Academic and policymaker)
It is a problem that the government and the Min-
istry of Health do not control food and nutrition
supplements advertisements (BG4; Patient associa-
tion manager)
Enough pressure is not being put on producers and
markets (. . .) you can see all sorts of conﬂicts of
interest, you just have to look at the Olympics (. . .)
we’re trying to promote healthy activity and all our
major sponsors are McDonalds and Coke (. . .) you
allow advertisers to make those sort of false links in
people’s mind between healthy activity and
McDonalds (UK10; Academic and policymaker).
Discussion
This study exposes the desires of the key infor-
mants for both reconﬁguration and the creation
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of new modes of functioning within the SSSC as
well as their views on the current state of aﬀairs.
While the SSSCs are at diﬀerent developmental
stages in the participating countries, various
issues could be observed that were common to
all of them. First, key informants from the six
partner countries described the ideal SSSC as
inclusive (in that it demands the participation of
multiple stakeholders at the micro-, meso- and
macro-levels), interdependent and patient-
centred. This archetype, presented in more detail
in the left diagram of Fig. 2, emphasizes the
importance of a range of interactions between
stakeholders at the micro- and meso-levels in the
SSSC as proposed in the chronic care model for
chronic care improvement.14 This demonstrates
the great impact that the chronic care model has
had on European stances in the battle against
chronic illness.
Furthermore, key informants from all of the
participating countries described practical reali-
ties that are far from the ideal SSSC. In
particular, the diﬃculty in bringing patients to
the centre of the system was observed across all of
the participants’ settings. The study identiﬁed
attitudinal and practical barriers to implementing
patient-centred approaches such as professionals
recurring to paternalistic practice when con-
fronted with a lack of resources, or the variability
in patient willingness to be involved in decision
making when they lack previous experience,
skills or health literacy. These barriers had been
previously identiﬁed in studies exploring per-
spectives regarding self-care strategies of other
populations such as health-care professionals
and patients.5,15–17 The fact that the same
sources of paternalistic attitudes and practices
towards caring for chronic illness had been
consistently identiﬁed as a deterrent for self-
care from a variety of perspectives reinforces
the grounds for suggesting that actions directed
at addressing latent causes of patient disem-
powerment could be sound and acceptable for
enhancing SSSC and consequently for spread-
ing the practice of self-care.
Study ﬁndings also suggest that patient relega-
tion to aminor role in the SSSC is also perpetuated
by the lack of capacity, representativeness and
independence of patient organizations for serving
as themeans for patients to inﬂuence health profes-
sionals’ practices and health-care policies.
Concerns regarding the capacity of European
patient organizations to advocate for patients have
been raised before, but not in terms of its impact
on the conﬁguration of SSSCs.18 Thus, this study
provides novel evidence to bring to light an impor-
tant area for intervention if SSSC is to be
redesigned as patient-centred and to be truly sup-
portive of self-care strategies.
Another ﬁnding observed across the studied set-
tings is the distortion in macro-level stakeholders’
practices and the relationships with stakeholders
at the micro-level. The inability of industry and
the media to self-regulate and reconcile their inter-
ests with society’s health interests have been
denounced previously and it appears to constitute
an enduring problem requiring genuine attention
from authorities.19–21
Thus, the cross-country examination carried
out in this study suggests that there are common
enduring barriers to enacting changes in health
systems which must be addressed to implement
new strategies for tackling chronic illness, such
as self-care. Study key informants assigned the
ultimate responsibility for addressing these bar-
riers to governments and authorities, who
should strive for truly enacting patient-centred
care by strengthening their strategies to address
the latent factors behind the inclination of
professionals and patients towards paternalistic
and medicalized approaches to care; and the
marginalization of patient capacity to inﬂuence
health services and policies. In other words,
authorities were said to be responsible for
promoting industry and the media social respon-
sibility, as well as patient associations’ growth
(so they can become more independent and
focus on advocating for patients).
The traditional strategies of governments for
encouraging corporate social responsibility,
namely ministerial leadership in identifying and
allocating risks, development of public–private
partnerships, subsidy of corporate social respon-
sibility activities and organizations, and
development of soft regulation, have shown lim-
ited eﬀectiveness.22 However, recent evaluations
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of public–private partnerships aimed at improv-
ing corporate social responsibility have provided
valuable insight into what can be done to
improve the strategies for engaging companies
and producing environmental gains for public
health. In particular, their eﬀectiveness could be
improved if they evolve, becoming evidence-
based, measurable and widespread, open to pub-
lic and formal scrutiny, and supported by both
appealing incentives (i.e. opportunities for
improving organizational reputation) and sanc-
tions for lack of commitment.23,24
Moreover, to bolster the patient associations’
independent growth and advocacy capacity,
researchers and patient associations have often
recommended that governments increase funding
and facilitate access of patient associations
to decision-making structures. However, this
governmental interference is not without disad-
vantages: patient associations may ﬁnd it diﬃcult
to maintain patient agenda when facing the need
for meeting criteria attached to subsidies; to
oppose government proposals; or to use non-
institutional or activist oppositional strategies to
inﬂuence decision making. For this reason,
recent literature proposes that governments cre-
ate less constrained subsidies that ‘come with
fewer strings attached’, last longer periods of
time and respond to public expenditure account
systems that take into account a broad set of
metrics that also evaluates their activities in
terms of relevance for their members.25
In this research, the involvement of a range of
countries with diﬀerent socio-economic, institu-
tional and health-care contexts posed major
advantages for improving the trans-European
understanding of how SSSCs should be charac-
terized and transformed. However, it also posed
challenges for data collection and analysis that
required attention so as to preserve the trustwor-
thiness and dependability of the ﬁndings.
Among them, the lack of equivalence of key con-
cepts and the variability in the composition of
the samples between the participating countries
stood out. Attention to conceptual nuances was
maintained in the adaptation of the interview
guides and in the development of the common
thematic framework and cross-cultural data
analysis clinics. The research team members
had knowledge of the structural and cultural
aspects of diﬀerent countries so that inter-
pretation errors stemming from cultural
misunderstandings could be avoided. Moreover,
eﬀorts were made to minimize variability across
samples that do not respond to national particu-
larities that need to be accounted for in the
development of intracountry relevant samples.
For example, sampling biases associated with
snowballing techniques for identifying potential
key informants were prevented by complement-
ing the sampling process with a review of policy
statements and organizational websites in each
partner country.
Conclusion
Further development and spreading of new
strategies for tackling chronic illness such as self-
care should be carried out if the chronic illness
pandemic is to be contained and the sustainabil-
ity of health systems is to be guaranteed. To
achieve this, SSSCs should be reoriented to truly
support a patient-centred approach to caring
that facilitates the eﬀective involvement and
coordination of multiple stakeholders at diﬀerent
levels. This requires a change in the persisting
paternalistic and medicalized attitudes among
patients and professionals, the growth and matu-
ration of patient associations, and an increase in
the social responsibility of both media and indus-
try. European authorities play a critical role in
creating environments that support public partic-
ipation. They should develop and introduce
enhanced public–private partnerships to improve
industry and the media social responsibility and
to oﬀer less constrained subsidies and modes of
participation for patient associations so they can
be more capable of advocating for patients.
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